Researchers developed an assay kit for TAT, then conducted a retrospective analysis to determine its ability to predict VTE in patients with cervical cancer.

Idraparinux, a long-acting derivative of fondaparinux, was recently shown to have an efficacy similar to that of traditional therapy in patients with DVT, but not in patients with PE. [66] Cancer ...

Symvess is a first-in-class bioengineered human tissue designed to be a universally implantable vascular conduit for use in arterial ...

Cerebral venous sinus thrombosis (CVST ... hormonal replacement therapy, pregnancy, and puerperium. Symptoms include nausea, seizures, severe focal neurological deficits, coma, and headache ...

The latest research published in the "Journal of Thrombosis and Haemostasis" suggests that exposure ... Our findings could ...

NDAQ:HUMA) Humacyte Provides Update on Commercial Launch and Pricing of Symvess(TM) (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma ...

We have compiled some of the more recent heartbreaking stories of much-missed animals who have sadly died at Colchester Zoo in years gone by.

Acute coronary syndrome (ACS) is a term used to describe a range of conditions resulting from the sudden reduction or ...

Research indicates that exposure to red light may reduce the risk of blood clots. These conclusions were drawn after a series ...

Humans and mice exposed to long-wavelength red light had lower rates of blood clots that can cause heart attacks, lung damage and strokes, according to research led by surgeon-scientists.

Charlie Allan suffered complete arterial thrombosis – a blood clot that develops in an artery - after an accident at home.